Anis AH - Search Results

1

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.

Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. Marra CA, et al. Among authors: anis ah. Soc Sci Med. 2005 Apr;60(7):1571-82. doi: 10.1016/j.socscimed.2004.08.034. Soc Sci Med. 2005. PMID: 15652688

2

The cost of COX inhibitors: how selective should we be?

Marra CA, Esdaile JM, Sun H, Anis AH. Marra CA, et al. Among authors: anis ah. J Rheumatol. 2000 Dec;27(12):2731-3. J Rheumatol. 2000. PMID: 11128654 No abstract available.

3

The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry.

Marra CA, Esdaile JM, Guh D, Fisher JH, Chalmers A, Anis AH. Marra CA, et al. Among authors: anis ah. Arthritis Rheum. 2001 Jun;45(3):240-5. doi: 10.1002/1529-0131(200106)45:3<240::AID-ART255>3.0.CO;2-I. Arthritis Rheum. 2001. PMID: 11409664 Free article. Clinical Trial.

4

Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.

Marra CA, Esdaile JM, Anis AH. Marra CA, et al. Among authors: anis ah. J Rheumatol. 2002 Dec;29(12):2507-12. J Rheumatol. 2002. PMID: 12465143

5

Lowering generic drug prices: less regulation equals more competition.

Anis AH, Guh DP, Woolcott J. Anis AH, et al. Med Care. 2003 Jan;41(1):135-41. doi: 10.1097/00005650-200301000-00015. Med Care. 2003. PMID: 12544550

6

Infliximab treatment of rheumatoid arthritis and Crohn's disease.

Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH. Nahar IK, et al. Among authors: anis ah. Ann Pharmacother. 2003 Sep;37(9):1256-65. doi: 10.1345/aph.1C039. Ann Pharmacother. 2003. PMID: 12921510 Review.

7

The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment.

Marra CA, Lynd LD, Esdaile JM, Kopec J, Anis AH. Marra CA, et al. Among authors: anis ah. Rheumatology (Oxford). 2004 Nov;43(11):1390-7. doi: 10.1093/rheumatology/keh334. Epub 2004 Aug 3. Rheumatology (Oxford). 2004. PMID: 15292531

8

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis.

Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A, Anis AH. Marra CA, et al. Among authors: anis ah. Med Care. 2004 Nov;42(11):1125-31. doi: 10.1097/00005650-200411000-00012. Med Care. 2004. PMID: 15586840

9

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. Bansback NJ, et al. Among authors: anis ah. Drugs. 2005;65(4):473-96. doi: 10.2165/00003495-200565040-00004. Drugs. 2005. PMID: 15733011 Review.

10

Gaps in care for rheumatoid arthritis: a population study.

Lacaille D, Anis AH, Guh DP, Esdaile JM. Lacaille D, et al. Among authors: anis ah. Arthritis Rheum. 2005 Apr 15;53(2):241-8. doi: 10.1002/art.21077. Arthritis Rheum. 2005. PMID: 15818655 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters